{"id": "375182", "url": "https://fevir.net/resources/Group/375182", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/comparator-group"], "versionId": "4", "lastUpdated": "2025-11-12T15:01:58.374Z"}, "text": {"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p>[No data.]</p></div>", "status": "empty"}, "type": "person", "title": "QUARTET USA Trial Control Group", "status": "active", "contact": [{"telecom": [{"value": "support@computablepublishing.com", "system": "email"}]}], "quantity": 30, "copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/", "extension": [{"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/cite-as", "valueMarkdown": "QUARTET USA Trial Control Group [Database Entry: FHIR Group Resource]. Contributors: Brian S. Alper, MD, MSPH [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 375182. Revised 2025-11-12. Available at: https://fevir.net/resources/Group/375182. Computable resource at: https://fevir.net/resources/Group/375182#json."}, {"url": "http://hl7.org/fhir/StructureDefinition/artifact-author", "valueContactDetail": {"name": "Brian S. Alper, MD, MSPH"}}, {"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status", "valueCodeableConcept": {"coding": [{"code": "active", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type", "display": "Active"}]}}], "publisher": "Computable Publishing LLC", "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": [{"code": "ACSN", "system": "http://terminology.hl7.org/CodeSystem/v2-0203", "display": "Accession ID"}]}, "value": "375182", "system": "https://fevir.net/FOI", "assigner": {"display": "Computable Publishing LLC"}}], "membership": "enumerated", "useContext": [{"code": {"code": "evidence-communication", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "Evidence Communication"}, "valueCodeableConcept": {"coding": [{"code": "ComparatorGroup", "system": "https://fevir.net/resources/CodeSystem/179423", "display": "ComparatorGroup"}]}}], "resourceType": "Group", "characteristic": [{"code": {"text": "Member of"}, "exclude": false, "description": "Enrolled in QUARTET USA Trial", "valueReference": {"type": "Group", "display": "Enrolled Group for QUARTET USA Trial", "reference": "Group/372797"}}, {"code": {"text": "Assigned to"}, "exclude": false, "description": "Assigned to Control group (candesartan 8 mg once daily)", "valueReference": {"type": "ActivityDefinition", "display": "Candesartan 8 mg once daily", "reference": "ActivityDefinition/375181"}}], "combinationMethod": "all-of", "description": "This Group Resource is referenced in an example for the EBMonFHIR Implementation Guide."}